Home › Prostate Cancer › Ohio › Parma
Prostate Cancer clinical trials in Parma, OH
3 studies for Prostate Cancer are looking for participants at sites in and around Parma (within about 30 miles). Open a study to see who can join and how to contact the study team.
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RecruitingPhase 3
- University Hospitals Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- University Hospitals Parma Medical Center, Parma
- Cleveland Clinic Cancer Center Independence, Independence · 5 mi away
- Cleveland Clinic Cancer Center Strongsville, Strongsville · 9 mi away
- and 1 more
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- UH Seidman Cancer Center at UH Avon Health Center, Avon · 17 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA60 studies
- St. Louis, MO47 studies
- San Francisco, CA45 studies
- Chicago, IL45 studies
- Seattle, WA44 studies
- Philadelphia, PA44 studies
- Nashville, TN43 studies
- Baltimore, MD42 studies
- Washington, DC38 studies
Other studies in Parma
- Ulcerative Colitis10 studies
- Steatotic Liver Disease7 studies
- Crohn's Disease7 studies
- Psoriatic Arthritis6 studies
- Lung Cancer5 studies
- Schizophrenia5 studies
- Endometrial Cancer5 studies
- Major Depressive Disorder5 studies
- Non-Small Cell Lung Cancer4 studies
- Cancer (all types)4 studies
- Ovarian Cancer4 studies
- Alzheimer's Disease4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.